PENCEAT MEDICAL LTD

Company Registration Number:
11154506 (England and Wales)

Unaudited abridged accounts for the year ended 31 March 2023

Period of accounts

Start date: 01 April 2022

End date: 31 March 2023

PENCEAT MEDICAL LTD

Contents of the Financial Statements

for the Period Ended 31 March 2023

Balance sheet
Notes

PENCEAT MEDICAL LTD

Balance sheet

As at 31 March 2023


Notes

2023

2022


£

£
Called up share capital not paid: 0 0
Fixed assets
Intangible assets:   0 0
Tangible assets: 3 264,299 229,449
Investments:   0 0
Total fixed assets: 264,299 229,449
Current assets
Stocks: 7,032 9,512
Debtors:   205,221 284,512
Cash at bank and in hand: 337 3,124
Investments:   0 0
Total current assets: 212,590 297,148
Creditors: amounts falling due within one year:   (50,074) (45,127)
Net current assets (liabilities): 162,516 252,021
Total assets less current liabilities: 426,815 481,470
Creditors: amounts falling due after more than one year:   (165,000) (210,000)
Provision for liabilities: 0 0
Total net assets (liabilities): 261,815 271,470
Capital and reserves
Called up share capital: 150,000 150,000
Share premium account: 0 0
Revaluation reserve: 00
Other reserves: 0 0
Profit and loss account: 111,815 121,470
Shareholders funds: 261,815 271,470

The notes form part of these financial statements

PENCEAT MEDICAL LTD

Balance sheet statements

For the year ending 31 March 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 10 March 2024
and signed on behalf of the board by:

Name: S Agarwal
Status: Director

The notes form part of these financial statements

PENCEAT MEDICAL LTD

Notes to the Financial Statements

for the Period Ended 31 March 2023

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

PENCEAT MEDICAL LTD

Notes to the Financial Statements

for the Period Ended 31 March 2023

2. Employees

2023 2022
Average number of employees during the period 35 25

PENCEAT MEDICAL LTD

Notes to the Financial Statements

for the Period Ended 31 March 2023

3. Tangible Assets

Total
Cost £
At 01 April 2022 229,449
Additions 100,925
Disposals 0
Revaluations 0
Transfers 0
At 31 March 2023 330,374
Depreciation
At 01 April 2022 0
Charge for year 66,075
On disposals 0
Other adjustments 0
At 31 March 2023 66,075
Net book value
At 31 March 2023 264,299
At 31 March 2022 229,449

PENCEAT MEDICAL LTD

Notes to the Financial Statements

for the Period Ended 31 March 2023

4. Loans to directors

Name of director receiving advance or credit: S Agarwal
Description of the loan: Directors loan
£
Balance at 01 April 2022 80,000
Advances or credits made: 57,485
Advances or credits repaid: 0
Balance at 31 March 2023 137,485